Pathology News

Navigating the Future: Implementing Digital Pathology
2025-12-02 14:00 - 15:00 (Europe/London) | Online
0000Days00Hrs00Min00SecRegister below! The webinar starts at 2 PM GMT, 3 PM CET, and 9 AM EST.
Join us for an insightful conversation on what it truly takes to implement a successful, scalable digital pathology service.
In this webinar, Christopher Parry, Digital Pathology Sales Specialist at Roche, and Paul Flavell, Programme and Portfolio Manager, draw on their combined expertise in cellular pathology, cloud migration, and digital transformation to explore the journey from vision to implementation.
Through a presentation and conversational Q&A format, they’ll unpack the key stages of digital adoption from defining why digitisation matters, to managing integration, networking, and storage requirements, and overcoming real-world challenges through strong partnerships and collaboration.
Learning Objectives

Why a network-wide digital pathology service requires more than just hardware.
How strong relationships have driven successful digital pathology deployment.
What benefits are already being realised and what the future holds as AI and algorithmic tools become part of routine diagnosis.

Register NowPresenters
Christopher Parry
With over 10 years experience within Cellular Pathology, Chris is now a Digital Pathology Sales Specialist at Roche, Chris is passionate about leveraging digital pathology and AI to transform cellular pathology. With a focus on driving diagnostic certainty and alleviating the significant backlogs within the field. Background includes roles in tissue diagnostics sales, as an applications consultant, and as a biomedical scientist in both the NHS and private sectors.
Paul Flavell
Paul is a highly experienced Programme and Portfolio manager, delivering large complex data center migrations, cloud migrations and cloud optimisation programmes of work across multiple industries sectors. 5 years with Roche leading teams to design and deliver digital solutions.

Optimizing the pathology workflow with Aiforia® Breast Cancer Suite
2025-11-26 14:00 - 15:00 (Europe/London) | Online
Join Aiforia to learn how AI technology can enhance precision, speed, and diagnostic accuracy in breast cancer diagnostics.
Pathologist and Aiforia’s Medical Director, Richard Doughty, will discuss his experiences working with breast cancer tissue samples in routine diagnostics. He will showcase a typical BC workflow with and without AI and explain how Aiforia’s AI seamlessly integrates to enhance every step, from sample analysis to diagnosis.
Aiforia®️ Breast Cancer Suite is the most comprehensive AI toolkit for breast cancer diagnostics, supporting the entire diagnostic workflow. It consists of six CE-IVD marked AI solutions with an optimized interactive user interface that assists pathologists in the histological grading of breast cancer, assessment of breast cancer IHC markers, and the detection of lymph node metastasis. The user can review, verify, and modify results, ensuring the highest quality of output.
Who should join?

Pathologists involved in the routine diagnostic workflow for breast cancer
Oncologists and other clinicians who rely on accurate and timely breast cancer diagnostics for treatment planning
Laboratory directors and administrators interested in implementing AI-powered digital pathology tools to improve efficiency and precision
Anyone involved in breast cancer diagnostics who wants to learn about the practical application of AI in histological grading, IHC marker assessment, and metastasis detection

Register NowSpeakers
Richard Doughty, DVM, MD, MSc
Medical Director at Aiforia Technologies

Consulting pathologist at Oslo University Hospital
Medical doctor and specialist in pathology with extensive diagnostic experience.
Qualified veterinarian with pathology expertise in pharmaceutical research and development.

Rute Pedrosa, PhD
Senior Field Application Scientist, Aiforia Technologies

Has worked at Aiforia for 2.5 years
PhD at Erasmus University Rotterdam, focusing on the pathogenesis of brain metastatic disease

AI in Clinical Digital Pathology: An introduction and live demonstrations of Aperio HALO AP and Aperio AI Store
2025-11-25 15:00 - 16:00 (Europe/London) | Online
0000Days00Hrs00Min00SecRegister below! The webinar starts at 4 PM CET, 3 PM GMT, and 10 AM EST.
Join Leica Biosystems for a dynamic one-hour session exploring how cutting-edge software and artificial intelligence are transforming clinical digital pathology. This webinar will showcase live demonstrations of the Aperio HALO AP Image Management Solution and Aperio AI Store.

Building Now for Tomorrow’s Future: Rob Monroe, MD, PhD, VP & Chief Scientific Officer, Oncology, Danaher Diagnostics, Chief Medical Officer, Leica Biosystems
Introduction and Demonstrations for Aperio HALO AP and Aperio AI Store: Bryce Brown, Director, Product Management, Leica Biosystems
Live Audience Q & A: Linda Fildey, Senior Manager, Global Customer Advocacy, Leica Biosystems (attendees are invited to participate in a live Q&A session with our experts to dive deeper into the technologies and innovations discussed).

Webinar learning objectives:

Discover how AI tools are empowering pathologists and histotechnologists with advanced tools to enhance diagnostic precision, streamline workflows, and support better patient outcomes.
Explore the capabilities of Aperio HALO AP and Aperio AI Store through live demonstrations, highlighting practical applications in real-world pathology settings.
Practical considerations on the importance of building future-ready digital pathology infrastructure

Register NowPresenters
Rob Monroe, MD, PhD, VP & Chief Scientific Officer, Oncology, Danaher Diagnostics, Chief Medical Officer, Leica Biosystems
Rob joined Danaher in January 2022 to help drive oncology initiatives for the Diagnostics Platform and lead Medical Affairs at Leica Biosystems. Over the course of his career, Rob has served in multiple Chief Medical Officer and Medical Director roles for diagnostics companies including Bio-Techne, Advanced Cell Diagnostics, Veracyte, and BioImagene. Before joining industry, Rob practiced pathology in the Central Coast of California following residency/fellowship training in Pathology at UCLA and Stanford and MD/PhD training at Harvard Medical School.
Bryce Brown, Director, Product Management, Leica Biosystems
Bryce Brown is an accomplished leader in digital pathology and molecular diagnostics, currently serving as Director of Product Management, Digital Pathology at Leica Biosystems. With over a decade of experience at Leica Biosystems, Bryce has held multiple strategic roles, including leadership in Artificial Intelligence and Machine Learning, where he helped shape product innovation across remote teams in the U.S.. Bryce has also worked as a Cytogenetic Hematological Chromosome Technologist at the Mayo Clinic, where he contributed to high-impact clinical diagnostics in hematological disorders. He holds a Bachelor of Science in Cellular and Molecular Biology from Winona State University.
Linda Fildey
Senior Manager, Global Customer Advocacy
Leica Biosystems

TIA Centre Seminar Series - Pathology knowledge-guided AI models in computational pathology
2025-11-21 11:00 - 12:00 (Europe/London) | Online
The Tissue Image Analytics (TIA) Centre hosts a seminar series for those interested in computational pathology. The series invites researchers and leaders in computational pathology and related fields to present their work and foster thought-provoking discussions.
This seminar features Professor Jin Tae Kwak from Korea University, Seoul, South Korea.
Abstract
Computational pathology is undergoing a profound transformation driven large-scale artificial intelligence (AI), particularly the seamless integration of multiple data modalities through multimodal large language models (MLLMs). In this talk, I will present our group’s recent efforts in developing knowledge-guided computational pathology tools that utilize vision-language models for various diagnostic tasks. I will discuss how vision-language models, combined with expert knowledge, can aid in analyzing complex tissue patterns, enhancing interpretability, and achieving accurate and reliable diagnostic performance.
Register NowBio
Jin Tae Kwak received his Ph.D. in Computer Science from University of Illinois at Urbana-Champaign, USA in 2012. He earned his Masters of Science degree in Electrical and Computer Engineering from Purdue University, USA in 2007 and his Bachelor of Engineering degree in Electrical Engineering from Korea University, Korea in 2005. In 2012, He joined Center for Interventional Oncology, Clinical Center, National Institutes of Health, USA as a Research Fellow. He served as a tenure-track faculty member in the department of Computer Science and Engineering at Sejong University from March 2016 to August 2020. He joined School of Electrical Engineering at Korea University in September 2020. His research interests include multimodal medical imaging, digital and computational pathology, and large-scale and efficient AI systems for medicine

HistoWiz x PathologyOutlines: Seamless Digital Slide Integration with PathologyMap™
2025-11-20 16:00 - 17:00 (Europe/London) | Online
0000Days00Hrs00Min00SecJoin HistoWiz and PathologyOutlines.com for an inside look at how their new partnership is transforming digital pathology publishing. This webinar will showcase how PathologyMap™, HistoWiz’s secure digital slide management platform, now integrates with PathologyOutlines.com to make research articles more interactive and accessible. Attendees will see firsthand how authors can easily upload digital slides, embed high-resolution images directly into articles, and provide readers with frictionless access to pathology content. Learn how this collaboration is setting a new standard for open-access education and discover tools that simplify workflows for authors, readers, and the pathology community at large.
Learning Objectives

Understand how PathologyMap™ integrates with PathologyOutlines.com to simplify digital slide sharing and publishing.
Identify the benefits of embedding interactive whole slide images within research articles for both authors and readers.
Explore how this collaboration supports open-access education and democratizes access to pathology data worldwide.
Recognize opportunities to adopt digital pathology tools that enhance learning, research dissemination, and clinical insights.

Register NowSpeakers
Akash Parvatikar, PhD
AI Scientist and Product Manager, HistoWiz
Kristi Marie
Managing Editor, PathologyOutlines.com

Carrefour Pathologie 2025
2025-11-19 - 2025-11-21 | CNIT Forest in Paris la Défense, 2 Le PARV de la Défense, Paris, 92800, France
The congress took place in a beautifully rehabilitated venue, designed to meet expectations and widely appreciated by participants. The 2024 edition was a great success, bringing together 1,486 participants (a record!) and receiving excellent feedback from both pathologists and exhibitors.
CARREFOUR 2025 will once again bring together professionals in Pathological Anatomy and Cytology for a unique moment of learning, exchange, and collaboration. The event will be held in person, with all sessions available afterwards as podcasts for registered participants via the Carrefour media library.
Register NowKey Features of CARREFOUR 2025
Scientific Programme designed by Professor Séverine Valmary-Dégano and the scientific committee.
Histoseminars on:

Colorectal tumors
Thyroid pathology
Ovarian pathology

Conferences by world-renowned French and international pathologists covering:

France Genomics 2025 program
Ethics and artificial intelligence
Pulmonary cytology and mediastinal pathology

Symposia Topics

Theranostic markers
Ecological transition and quality
Bilio-pancreatic cytology
Feto-placental pathology
Organ transplant rejection

Interactive Session

Focused on the management of prostate biopsies — one of the most anticipated sessions of the event

AIP Day (Friday)

Theme: Pulmonary Tumor and Pseudotumoral Pathology

Medico-Technical Sessions

The Macroscopic Technician: Crossed Views and Feedback
The Cyber-ACP Attack: Action / Reaction / Anticipation

TIA Centre Seminar Series – Too Many Models, Too Few Benchmarks: Addressing the benchmarking crisis in AI for pathology
2025-11-17 14:00 - 15:00 (Europe/London) | Online
The Tissue Image Analytics (TIA) Centre hosts a seminar series for those interested in computational pathology. The series invites researchers and leaders in computational pathology and related fields to present their work and foster thought-provoking discussions.
This seminar features Professor Jana Lipkova from the University of California, Irvine, USA.
Abstract
The field of AI in pathology is experiencing a benchmarking crisis. New models emerge weekly, each claiming superiority over predecessors, yet the community lacks rigorous, reproducible tools to validate these claims. In this talk, I will present two open benchmarks from our group to address this gap. The first benchmark systematically evaluates state-of-the-art pathology foundation models (FMs) for survival prediction in oncology. We assess model generalization across multiple external cohorts, compare architectural paradigms (patch- vs. slide-level, uni- vs. multimodal), probe model interpretability and investigate weather FM allow to build pan-cancer generalists model that replace disease-specific models and generalize to rare cancers and conditions not seen during the model training? The second benchmark introduces a framework for safe AI deployment in pathology, focusing on out-of-distribution (OOD) detection and model “guardrails.” We propose a new taxonomy for OOD scenarios in pathology and a public benchmark that stress-tests existing OOD models across diverse data shifts and real-world variability. Both benchmarks, including all datasets, standardized splits, and evaluation protocols, are publicly released to serve as standards for model evaluation and comparison, thereby accelerate further advances and deployment of AI in pathology.
Register NowBio
Jana is an Assistant Professor at the University of California, Irvine, with joint appointments in the School of Medicine, School of Biomedical Engineering, and the School of Computer Science. She completed her postdoctoral fellowship in the AI for Pathology group at Harvard Medical School, under the mentorship of Dr. Faisal Mahmood. Prior to that, she earned her Ph.D. in computer-aided medical procedures from the Department of Radiology at the Technical University of Munich. Jana leads the OctoPath Lab (http://octopath.org/), which develops AI methods for diagnosis, prognosis, and treatment optimization in histopathology and beyond.

Mastering Image Quality Control with AIRA Matrix
2025-11-13 16:00 - 17:00 (Europe/London) | Online
0000Days00Hrs00Min00SecRegister below! The webinar starts at 5 PM CET, 4 PM GMT, and 11 AM EST.
Artificial intelligence is transforming how laboratories and life science organizations approach quality control. This webinar will answer the key question: Why address quality control issues with AI? We’ll explore the benefits of AI-driven solutions, highlight differentiating features, and provide a live product demonstration to show how Aira Matrix can improve efficiency and consistency in lab workflows. Attendees will gain practical insights into how AI can help reduce errors, streamline processes, and support more reliable outcomes.
The session will be led by Marco Comianos, who heads Aira Matrix’s commercial organization in the United States and Canada. With over 25 years of experience in sales, marketing, and commercial leadership across healthcare and life sciences—including roles in medical imaging, EMR, and healthcare AI—Marco brings deep expertise in aligning innovative technologies with real-world clinical and research needs.
Learning Objectives

Why addressing quality control with AI matters
How Aira Matrix differentiates itself in the market
Key product features and their impact on efficiency
A live demo of the platform in action

Register NowPresenter
Marco Comianos heads Aira Matrix’s commercial organization in the United States and Canada. He has over 25 years of experience in sales, marketing and commercial leadership in the Healthcare and Life Sciences industries, at a broad range of medical imaging, EMR and healthcare AI companies. He holds a Bachelor of Science Degree in Business Administration

AMP 2025 Annual Meeting & Expo
2025-11-11 - 2025-11-15 | Boston Convention and Exhibition Center, Boston, MA, United States
0000Days00Hrs00Min00SecJoin leading experts in molecular diagnostics at the AMP 2025 Annual Meeting & Expo, the premier event hosted by the Association for Molecular Pathology. This international gathering offers cutting-edge insights, hands-on workshops, and a dynamic expo showcasing the latest innovations in precision medicine and clinical genomics.
Key topic areas include:

Genetics
Hematopathology
Infectious Diseases
Informatics
Solid Tumors
Technical Topics
Education & Emerging Areas

Whether you’re advancing laboratory practices, exploring new technologies, or shaping the future of molecular medicine, AMP 2025 is the place to connect, learn, and lead.
Register Now

TIA Centre Seminar Series - Scaling Multiplexed Protein Imaging Analysis for Subcellular-resolution Pathology
2025-11-10 14:00 - 15:00 (Europe/London) | Online
The Tissue Image Analytics (TIA) Centre hosts a seminar series for those interested in computational pathology. The series invites researchers and leaders in computational pathology and related fields to present their work and foster thought-provoking discussions.
This seminar features Malte Kuehl from Aarhus University, Denmark.
Abstract
Proteins and their spatial distribution constitute the functional foundation of biology, offering critical insights into health and disease. However, probing pathological tissues at subcellular resolution remains challenging, from experimental design through image acquisition to computational analysis. I will present our recent work on Pathology-oriented multiPlexing (PathoPlex) published in Nature, which introduces key innovations spanning quality control, experimental design, and image acquisition, alongside spatiomic, a novel software library that accelerates spatial proteomics analysis at the pixel level and beyond. Finally, I will discuss how these developments, combined with advances in spatial statistics, agentic AI, and collaborative community efforts in open-source software, offer potential pathways for addressing remaining challenges in spatial proteomics.
Register NowBio
Malte Kuehl studied medicine at the University of Hamburg, where he joined the Institute of Medical Systems Biology and the III. Medical Department to begin his Doctor of Medicine degree. In 2023, he joined the Complex Tissue Lab at Aarhus University, led by Prof. Puelles, as a postdoc. His primary research interests include spatial omics, image analysis, and agentic AI.

3rd Spatial Biology Congress: Asia
2025-11-10 - 2025-11-11 | Lee Kong Chian School of Medicine – NTU Singapore (Novena Campus), Singapore
0000Days00Hrs00Min00SecGlobal Engage is pleased to announce the 3rd Spatial Biology Congress Asia, returning to Singapore on 5th and 6th November 2025. This prestigious event continues to serve as a hub for spatial biology experts from academia, biotech companies, and the pharmaceutical industry, coming together to share cutting-edge insights and foster collaborations that push the boundaries of this rapidly evolving field.
Run as single-track, over 2-day, this year’s edition will stage more than 15 top scientists presenting the latest discoveries in using spatial multi-omics tools to uncover molecular insights through the following sessions:

Spatial genomics, transcriptomics, proteomics, metabolomics, and lipidomics
Computational & data analysis integration
Spatial profiling
Image analysis, AI and digital pathology for spatial
Spatial biology in therapeutic areas
Spatial omics in plant biology

If you are looking to stay at the forefront of spatial biology, gain unparalleled insights from leading scientists, and expand your professional network in this thriving field, then this meeting is not to be missed.
Register NowWhy Attend?

1
Connect with researchers, industry leaders, and potential collaborators from across Asia and beyond. Networking can facilitate partnerships and foster collaborative projects that enhance your team’s research efforts.

2
Gain access to cutting-edge research and developments in spatial biology, including advancements in imaging technologies, spatial transcriptomics, and multi-omics approaches.

3
Learn from leading experts in the field through keynote presentations, workshops, and panel discussions that provide valuable insights into the applications of spatial biology in various research areas.

4
Cross-Disciplinary Perspectives: Engage with professionals from diverse disciplines, including molecular biology, pathology, and bioinformatics, allowing your team to gain new perspectives and strategies for tackling complex biological questions.

5
Explore the latest tools and technologies available in the field of spatial biology. Understanding these innovations can help your team stay at the forefront of research and improve experimental outcomes.

6
Stay updated on emerging trends and future directions in spatial biology, helping your team align research goals with industry needs and advancements.

DP-AI 9.0 2025
2025-11-06 - 2025-11-08 | Google Headquarters, Chicago, Chicago, IL, United States
0000Days00Hrs00Min00Sec
Friday Sessions at Google Headquarters, Chicago, Illinois
Saturday Lab Tours at Endeavor Health, Evanston, Illinois

The first day will feature presentations by local and international experts at Google Headquarters in Chicago, IL. This is a unique opportunity for attendees to learn about Endeavor Health’s innovative approach to integrating digital pathology and AI into their laboratory systems alongside comparative use cases from other hospital systems across North America.
On the second day, attendees will be shuttled to Endeavor Health in Evanston to tour multiple laboratory spaces, following specimen collection, processing, and delivery to pathologist workstations and analysis.
Programming Themes:
1) Institutional/Clinical Practice and Vendor Collaboration
2) DICOM and its role in DP-AI
3) Digitization, Automation, and DP-AI for building the AP Lab of the Future
4) The Role of Foundation Models, Generative AI/LLMs, and Agentic AI in Pathology, with a deep dive into the Current State of Regulatory Affairs in DP-AI
Register Now

UKNEQAS CPT Annual Participant Meeting 2025
2025-11-04 | The Parkgate Hotel, Cardiff, Westgate Street, Cardiff, CF10 1DA, United Kingdom
0000Days00Hrs00Min00SecFuture Innovations and Investments
Leading The Future by Creating It
This event will centre on the future of Cellular Pathology, exploring innovations, technological advancements, and the latest regulatory changes shaping the field. Key discussions will highlight how these developments impact laboratory operations and the workforce. In addition, breakout sessions and Q&A opportunities with expert coordinators will provide practical insights into addressing everyday challenges faced in the field.
Register Now

6th NHS Pathology Conference: Improving NHS diagnostics
2025-11-04
0000Days00Hrs00Min00SecClinical Diagnostics & Medical Sciences
Current Landscape:
Pathology is increasingly becoming a collaborative and interdisciplinary field, with a strong focus on integrating innovative technologies and practices. This shift is essential to meet the growing demands of modern healthcare, where the challenges of disease management, diagnostics, and treatment require cutting-edge solutions and cross-border cooperation.
Timeliness of Event:
This conference is especially relevant as healthcare systems face the dual pressures of managing current patient demands and integrating new technologies into pathology services. With the rapid evolution of healthcare needs and the advent of new diagnostic tools, the event provides a timely platform for discussing how to optimize pathology services across regions and disciplines.
Register Now

Key Subjects:

Pathology Beyond Borders: Integrating Innovation and Collaboration Across Disciplines: Exploring how international collaboration and innovative approaches are reshaping pathology, breaking down silos, and improving global health outcomes.
MES Procurement Approach: A detailed discussion on the strategies and best practices for procuring Managed Equipment Services (MES), ensuring efficient and cost-effective delivery of pathology services.
Fire Panel Discussion: Cross-region Learnings: A dynamic exchange of insights from various regional pathology networks, focusing on shared challenges and solutions, operational strategies, and enhancing cross-region collaboration.
Pathology 2.0: Pioneering Tech Advancements Shaping Future Services: Delving into the latest technological innovations such as AI, digital pathology, and next-generation sequencing that are revolutionising pathology services and setting the stage for the future.
Local Pathology Networks: Examining the role of local pathology networks in managing demand and capacity, ensuring quality service delivery, and optimising resource utilisation.
Managing Demand and Capacity: Addressing the operational challenges in pathology, including strategies for efficient demand management and capacity planning to meet the needs of modern healthcare.

Why Attend:
Attendees will gain valuable insights into the future of pathology, with a focus on integrating innovative technologies, optimising procurement processes, and enhancing cross-region collaboration. This event is an essential opportunity for professionals to learn from experts, share best practices, and explore new approaches to managing the growing complexities of pathology services.

ACCESS25 - The Future of Precision Medicine Starts at the Moment of Diagnosis
2025-10-28 15:30 - 16:30 UTC | Online
0000Days00Hrs00Min00SecJoin Access25 on October 28 to discover how Proscia is removing one of the biggest barriers to realizing precision medicine — access to the right patients, at the right moment, with the right data.
With the launch of Proscia Aperture™, biopharma leaders will discover how to automatically identify trial and treatment candidates at the moment of diagnosis—accelerating recruitment and advancing novel therapies.
Clinical lab leaders will learn how Aperture elevates the lab’s strategic role in the precision medicine ecosystem while creating new revenue streams.
And for everyone attending, the Partner Expo will feature breakthroughs in pathology AI, next-generation infrastructure, and enterprise solutions—delivered by the strongest ecosystem in the industry.
Register Now

TIA Centre Seminar Series - Conformal Quantification of Predictive Uncertainty in Health AI
2025-10-27 14:00 - 15:00 (Europe/London) | Online
The Tissue Image Analytics (TIA) Centre hosts a seminar series for those interested in computational pathology. The series invites researchers and leaders in computational pathology and related fields to present their work and foster thought-provoking discussions.
This seminar features Dr Tapabrata (Rohan) Chakraborty from UCL, London, UK.
Abstract
For AI to be trusted for use in high risk applications like healthcare, it is important to ensure (AI Assurance) that the predictive uncertainty is within guaranteed bounds which can be achieved through conformal prediction based calibration at user defined level of significance.
Register NowBio
Rohan is a Theme/Group Lead in Frontier AI Assurance at the Alan Turing Institute and a Principal Research Fellow at UCL Cancer Institute. He leads TRAIL, the Transparent and Responsible AI Lab shared between UCL/Turing. Rohan is an invited expert in Responsible AI with the Global Partnership on AI and an Editor with Springer Nature Computer Science. Rohan has a PhD in Computer Science and worked as a postdoctoral researcher at the University of Oxford where he continues to an Honorary Fellow of Linacre College and a Lecturer in Computer Science with Christ Church College.

AISight Dx Digital Pathology Platform: Live Deep Dive
2025-10-23 16:00 - 17:00 (Europe/London) | Online
0000Days00Hrs00Min00SecJoin PathAI to learn how AISight Dx supports modern pathology workflows at enterprise scale.
In this webinar, PathAI will show how AISight® Dx supports modern digital pathology workflows at scale, including seamless slide management, flexible collaboration, and interoperability across a broad range of whole-slide imaging scanners, and will explain what PCCP means for ongoing updates and customer value.
You’ll also see a live demonstration with case-based examples covering slide navigation, AISight Live for synchronous and asynchronous collaboration, annotation tools, and the caselist dashboard.
What you’ll learn

What FDA 510(k) clearance with a PCCP means in practice for AISight Dx and your roadmap
How pathologists and lab leaders can standardize workflows, collaborate across teams, and stay ready for future feature updates enabled under the PCCP
Live demo: lightning-fast slide navigation and manipulation, measurements and annotations, real-time and asynchronous collaboration with AISight Live, case list triage, search, filters, and workflow handoffs

Register Now

Multi-Omics Analysis Demonstrates Repetitive Head Impacts Induce Neuronal Loss and Neuroinflammation in Young Athletes
2025-10-21 16:00 - 17:00 (Europe/London) | Online
0000Days00Hrs00Min00SecLearn how HALO image analysis is helping to advance the understanding of chronic traumatic encephalopathy!
SummaryRepetitive head impacts (RHI) sustained from contact sports are the largest risk factor for chronic traumatic encephalopathy (CTE). Currently, CTE can only be diagnosed after death and the multicellular cascade of events that trigger initial hyperphosphorylated tau (p-tau) deposition remain unclear. Further, the symptoms endorsed by young individuals with early disease are not fully explained by the extent of p-tau deposition, severely hampering development of therapeutic interventions. Using genomics, spatial transcriptomics, and histology it was observed that RHI exposure associates with a multicellular response in young individuals (<51 years old) prior to the onset of CTE p-tau pathology that correlates with number of years of RHI exposure. SPP1+ inflammatory microglia, angiogenic and inflamed endothelial cell profiles, reactive astrocytes, and altered synaptic gene expression in excitatory and inhibitory neurons were identified in all individuals with exposure to RHI. Surprisingly, elevation in collagen deposition around blood vessels that might be related to long term disease outcomes was also observed. Overall, these results provide robust evidence that multiple years of RHI exposure is sufficient to induce lasting cellular alterations that may underlie p-tau deposition and help explain the early pathogenesis in young former contact sport athletes.
Learning Objectives
Understand how HALO image analysis can assist in characterizing pathology in neurodegenerative diseases
Understand how HALO AI can be used to identify unique cell populations with complex, varied shapes
Explore how genomic data can be validated using histologic images analysis

Register NowPresenterJonathan Cherry, PhD
Research Health Scientist
VA Boston Healthcare System
Director, Digital Pathology Core & Research Neuropathologist
Boston University Alzheimer’s Disease Research Center and Boston University Chronic Traumatic Encephalopathy Center
Assistant Professor of Pathology and Laboratory Medicine
Boston University Avedisian & Chobanian School of Medicine
Dr. Cherry is an Assistant Professor of Pathology and Laboratory Medicine. He completed his undergraduate studies with a BS in biology at Ursinus College in 2008, earned his doctoral degree in Pathology from the University of Rochester in 2015, and joined the McKee laboratory as a postdoctoral researcher the same year. He was appointed as an assistant professor at Boston University School of Medicine in 2019. Dr. Cherry also holds a research health scientist position within the VA Boston Healthcare System. His laboratory space is located at the Jamaica Plain VA hospital where he performs his research and helps support the UNITE brain bank.
Dr. Cherry’s research interests focus on understanding how neuroinflammation after repetitive traumatic brain injury contributes to CTE pathogenesis. Specifically, Dr. Cherry seeks to identify what role microglia and inflammatory cytokines play in the early onset of hyperphosphorylated tau accumulation and spread.
Dr. Cherry’s research also extends to histology analysis and machine learning. He is the director of the BU digital pathology core. This research entails exploring novel ways to analyze human postmortem tissue using machine learning algorithms for neuropathologic targets and better characterize pathology across a spectrum of neurodegenerative diseases including Alzheimer’s disease, chronic traumatic encephalopathy, frontotemporal lobar degeneration, motor neuron diseases, and others.

Conference on Artificial Intelligence in Medical Imaging
2025-10-20 - 2025-10-21 | University of California, Irvine, CA, United States
0000Days00Hrs00Min00Sec

CMIMI is now SIIM-CAIMI!

New name. Sharper focus. Same cutting-edge research.

Unparalleled Research Focus

In-depth talks from top AI and imaging research centers with live Q&A
A space to test ideas, challenge norms, and refine AI approaches
Accepted abstracts published in the Supplement to the Journal of Imaging Informatics in Medicine

Immersive Scientific Discussions

Deep dives into methods, results, and clinical relevance
Discussions on AI bias, model generalizability, and regulatory considerations
Case study-driven conversations connecting theory to real-world impact

A Multidisciplinary Community

Connect with researchers, clinicians, and industry leaders in an intimate setting
Build partnerships across academia and industry
Be part of a welcoming environment for trainees and early-career professionals

AI in Action – From Research to Real-World Applications

Cutting-edge model development for accuracy and explainability
Real-world AI integration in imaging workflows
Ethics and regulation for responsible AI deployment

Register Now

ESMO Congress 2025
2025-10-17 - 2025-10-21 | Messe Berlin, Messedamm 22, Berlin, 14055, Germany
0000Days00Hrs00Min00SecThe ESMO Congress is a highly influential global oncology platform for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world.
ESMO 2025 will be a place where groundbreaking discoveries, cutting-edge treatments and a collaborative approach converge to shape the future of cancer care.
You will be able to learn from internationally renowned experts, engage in thought-provoking discussions and connect with fellow oncology professionals that are driving advancements in diagnosis, treatment and survivorship.
A comprehensive educational and scientific programme will foster exchange and debate of translational cancer science, showcase first announcements of potentially practice changing data and stimulate multidisciplinary discussions to improve treatment options for our patients.
Learning objectives

To review and be updated on prevention, screening and early diagnosis of cancer
To be updated on the latest breakthroughs in basic science, translational and clinical cancer research
To analyze and understand the clinical perspective of the scientific advances in cancer biology, diagnostics, and new treatments
To learn the optimal roles of novel diagnostics and treatments for patients with cancer

Register NowMeet Our Partner

Meet Mindpeak, a pioneer in AI-powered pathology solutions helping labs accelerate cancer diagnostics with precision and efficiency.
Catch them at ESMO 2025 — Booth #4010.
Discover how AI is reshaping the future of oncology.

Accreditation
ESMO-MORA: The Congress programme will be accredited with ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. It also guarantees that a certified medical oncologist has continued to update her/his knowledge and still possess the necessary skills and standards for the practice of medical oncology. See here for further details .
Disclaimer
ESMO is a scientific and professional, non-political and non-religious organisation. ESMO will not accept responsibility for any comments or remarks made during any of our events by session chairs, invited speakers, presenters, members or any other contributor, formally or informally, which might cause offence or be perceived as being biased.
The experts invited by ESMO as abstract Discussants are selected on an individual basis to provide their own interpretation of the data and are not acting as ESMO spokespersons.
All Speakers and Discussants are required to declare their interests, if any, and include a Declaration of Interest (DOI) slide at the start of their presentation(s).
The ESMO recommendations on the clinical utility of new drugs are only presented in the ESMO Clinical Practice Guidelines and such recommendations represent the only official position of ESMO.

Masterclass Webinar: Admin and Metadata Options in HALO Link
2025-10-16 16:00 - 17:00 (Europe/London) | Online
0000Days00Hrs00Min00SecLearn how to maximize the efficiency, customization, and data management capabilities of your HALO Link deployments!
SummaryJoin Indica Labs for this Masterclass Webinar designed for system administrators who want to maximize the efficiency, customization, and data management capabilities of their HALO Link deployments. This session will provide an in-depth review of the Admin Dashboard, highlighting tools for managing users, groups, and permissions, and explore the new Diagnostics Monitor tool for troubleshooting image viewing performance bottlenecks.

The webinar will also dive into metadata management, including how to create custom fields that support better data organization. Whether supporting a large research team or managing multi-site deployments, this session will equip administrators with practical strategies to tailor HALO Link to their needs, reduce administrative burden, and empower users to work more efficiently.

Learning Objectives
Learn about all the functionality in the current Admin Dashboard in HALO Link
Learn how the new opt-in Diagnostics Monitor feature (available in HALO Link 4.2) provides information for troubleshooting performance bottlenecks with image viewing
Learn about tools to manage users, permissions, and user groups
Learn about creating and managing system metadata fields

Register NowPresentKat Latimer
HALO Link Associate Product Manager
Indica Labs
Kat Latimer earned a ME in Biomedical Engineering from Colorado State University in 2025 and BS in Biochemistry from the University of New Mexico in 2018. Her graduate studies focused on tissue engineering and the use of biomaterials for wound healing. During her undergraduate studies, Kat participated in several research opportunities including investigating the role of cellular adhesion proteins in HPV oncogene expression. In 2020 she joined Indica Labs as a Software Quality Assurance Analyst. In 2021 she transitioned to the Product Management team and has since been promoted to the HALO Link Associate Product Manager role where she works closely with the software developers creating new features to improve the user experience.

Spatially Resolved Transcriptomics and Graph-based Deep Learning Improve Accuracy of Routine CNS Tumor Diagnostics
2025-10-15 15:00 - 16:00 (Europe/Paris) | Online
0000Days00Hrs00Min00SecRegister below! The webinar starts at 3 PM CET, 2 PM BST, and 9 AM EST.
Spatially resolved transcriptomics and graph-based deep learning are transforming how researchers approach and understand central nervous system (CNS) tumors. In this webinar we will deep dive into a publication that highlights how the NePSTA (neuropathology spatial transcriptomic analysis) framework combines advanced RNA sequencing technologies with neural network analyses to uncover detailed gene expression landscapes directly within tissue samples—even in complex or ambiguous cases. By mapping gene activity across individual tumor regions, these tools reveal previously hidden molecular characteristics, allow for more granular tissue classification, and address challenges posed by compromised sample quality.
Learning Objectives:

Understand the challenges of conventional CNS tumor diagnostics and how spatial transcriptomics addresses them.
Learn the basics of spatially resolved transcriptomics and how graph-based deep learning is applied in neuropathology.
Compare spatial transcriptomics with traditional molecular techniques such as DNA methylation profiling and next-generation sequencing.

Register NowSpeaker:
Prof. Felix Sahm
Prof. Dr. Dr. med. Felix Sahm, MBA is Vice-Chair of the Department of Neuropathology and Head of Molecular Neuropathology
University of Heidelberg
An internationally recognized expert in brain tumor diagnostics, he has authored over 500 publications, including landmark studies shaping the WHO classification of CNS tumors. His research focuses on integrating molecular and multi-omic approaches to improve precision diagnostics and patient care.

TIA Centre Seminar Series - Towards Multimodal AI for Personalized Cancer Treatment
2025-10-13 14:00 - 15:00 (Europe/London) | Online
The Tissue Image Analytics (TIA) Centre hosts a seminar series for those interested in computational pathology. The series invites researchers and leaders in computational pathology and related fields to present their work and foster thought-provoking discussions.
The next seminar will take place on Monday, 13 October, from 2–3 p.m. UK time. The Centre is delighted to announce that the session will feature Dr. Nadieh Khalili from Radboud UMC, The Netherlands, who will be joining online.
Abstract
The integration of diverse data types—such as histopathology, radiology, and omics—offers a powerful opportunity to develop AI models that improve cancer diagnosis and treatment selection. In this talk, I will present recent efforts from our group in developing and validating multimodal deep learning frameworks that predict treatment-relevant biomarkers directly from routine diagnostic images. I will highlight case studies in bladder and prostate cancer and discuss challenges related to data harmonization, model generalization, and clinical translation.
Register NowBio
Dr Nadieh Khalili is an Assistant Professor in AI at Radboud UMC, where she leads research at the intersection of deep learning, digital pathology, and multi-modal data integration. Her work focuses on developing clinically meaningful AI tools for cancer diagnosis and treatment response prediction. She has a background in biomedical engineering and previously worked in R&D roles in industry. Dr Khalili is also actively involved in organizing scientific events and is a board member of the European Society of Digital Pathology.

2nd Annual Congress of Asian Society of Digital Pathology
2025-10-10 - 2025-10-12 | JW Marriott Mumbai Sahar, Mumbai, India
0000Days00Hrs00Min00SecPixels to Practice: Advancing Digital Pathology in Asia
What to Expect at ASDP 2025Where Pathology Meets AI: The Future of Diagnostics Begins
The Asian Society of Digital Pathology (ASDP) Conference 2025 will serve as a pivotal meeting point for leaders in medicine, artificial intelligence, and industry. This event brings together a diverse community of clinicians, researchers, technologists, and decision-makers who are shaping the future of diagnostic practice.— and innovation into impact.
Conference Highlights:

Visionary keynote presentations from internationally recognised pioneers in AI and digital pathology
Groundbreaking research from leading laboratories and academic institutions
Live demonstrations showcasing AI tools that are transforming diagnostic workflows
Expert-led panels addressing regulatory pathways and clinical adoption
Networking opportunities with global experts, innovators, and healthcare policymakers

Who Should Attend:
From clinicians and computational scientists to regulatory experts and healthcare leaders, ASDP 2025 offers valuable insights and practical knowledge for anyone driving progress in digital diagnostics. This is where knowledge translates into innovation — and innovation into impact.
Register Now

Pathology Vision 2025
2025-10-05 - 2025-10-07 | Manchester Grand Hyatt, San Diego, United States
0000Days00Hrs00Min00SecCONNECT WITH INDUSTRY LEADERS,
AND THE FUTURE.
Pathology Visions brings together 800+ experts and peers across the field of digital pathology to address real-world, practical applications of digital pathology today, as well as the future of the field through new technologies and developments.
If you are a clinician or a researcher, a technician or a trainee, PathVisions is the place for you.
Your industry is changing. Are you keeping up?
Register NowLook for SIIM at the Digital Pathology Association (DPA)’s Pathology Visions 2025.
Attend the SIIM Companion Meeting: The Spectrum of Pathology Resources at SIIM: form Basic Science to Pragmatic Approaches to Pixels on October 5 and/or come to Booth #103 for a demo of our Virtual Hospital SIIMulator (VHS), an online sandbox for DICOM, HL7, FHIR.
SIIM Companion Meeting: The Spectrum of Pathology Resources at SIIM: from Basic Science to Pragmatic Approaches to PixelsSun, Oct 5
11:00AM – 12:00PM PT
Seaport Ballroom

The Challenges of Digital Pathology Conversion: Transitioning from traditional practices to digital pathology focused around the DICOM standard presents unique challenges, from system integration to data management. We will discuss these challenges in detail and introduce SIIM’s tools and resources to help pathologists and institutions navigate this conversion. Learn about best practices for overcoming common obstacles, optimizing workflows, and ensuring smooth implementation.
The Breadth of Research in Pathology Imaging at SIIM: SIIM is at the forefront of imaging informatics research, including in the field of pathology, based on successes of imaging standardization in radiology. This segment will explore SIIM’s extensive research efforts that are driving innovation in pathology imaging. We will showcase studies, collaborations, and advancements that will shape the future of digital pathology, with a focus on imaging technologies and their application in diagnostic workflows.
SIIM’s Commitment to Strategic Technical Leadership and Education in Digital Pathology: As part of our mission to empower imaging professionals, SIIM can provide strategic leadership and education in digital pathology imaging informatics. This section will highlight our ongoing initiatives to advance technical expertise, provide training programs, and support the integration of emerging technologies into pathology practice. Learn how SIIM is paving the way for pathologists.

Adapt or Fall Behind: Why the Best Labs Use AI
2025-10-01 15:00 - 16:00 (Europe/London) | Online
0000Days00Hrs00Min00SecArtificial intelligence is reshaping the lab landscape—not in the future, but now. In this webinar, we’ll explore why adopting AI is no longer optional for modern labs and share real-world insights from clinical leaders who have already taken the leap. Learn how labs in anatomic pathology, microbiology, cytology, and more are using AI to impact their staff and the patients they serve—and the lessons they’ve learned along the way.
Presenter

Dr. Chen is a leader in digital and computational pathology, holding a medical degree from the Mayo Clinic Alix School of Medicine and a master’s in Global Medicine from USC. She completed her anatomic pathology residency at Brigham and Women’s Hospital and an NIH/NCI postdoctoral fellowship in computational pathology at Harvard Medical School and Mass General Brigham. Before joining Techcyte, Dr. Chen led digital pathology initiatives at a cancer pharmaceutical company, driving advancements in AI-powered diagnostics.

Register Now

Precision Medicine: Redefining the Future of Healthcare
2025-09-30 - 2025-10-01 | QEII Centre, London, UK, London, United Kingdom
0000Days00Hrs00Min00Sec

Delivering Personalized Treatments

Join Biomarkers & Precision Medicine UK, an immersive event now in its 20th year, spotlighting the latest trends and tools in biomarker research. This year’s agenda also includes dedicated programmes on Spatial Biology for Precision Medicine and Digital Pathology & AI. The event gathers leading experts from global pharmaceutical companies, pioneering biotech firms & startups, and leading academic & healthcare institutions, all contributing to various therapeutic areas and stages of drug development, clinical trials, and precision patient treatments.

What is Biomarkers & Precision MedicineTargeted therapies are reframing the outlook for human health creating unprecedented scope for life-changing targeted treatments.
Are you ready to participate in this shared opportunity? Do you have the knowledge, strategy, tools and connections in place?
Precision Medicine provides the platform for you to learn, engage and collaborate across the entire targeted therapy R&D ecosystem — an interdisciplinary community of specialists in pharma, biotech, academia and healthcare.
Biomarkers & Precision Medicine UK, takes place on September 30-1 October in London, UK. Running across two full days, with 16 tracks across three dedicated programmes it’s the must attend event for those involved in bringing next-generation personalized treatments to market
Register Now

Why attend?

Expand your knowledge
Let subject specialists take you further and deeper.
With comprehensive learning in oncology, neuroscience and key complementary areas.
Build the partnerships you need
Identify, meet and collaborate with the people your strategy requires.
Start working with those who share your goals with 200 hours of pre-arranged 1-2-1s.
Join the conversation
Meet like-minded peers, expand your network and engage in interdisciplinary discussion on the latest thinking and practice.
See what’s in the pipeline
Our events are where innovations land.
Be at the showcase and meet the people behind technologies to give you the edge.
Understand the competitive landscape
Learn what others in your field are doing.
Evaluate their successes (and failures) and set your own benchmarks.
Harness AI & machine learning
AI & machine-learning tools will be critical in unlocking growth.
See the technology in action and speak to those who can help you implement it.

Evaluation of HER2-Low and Ultralow Status of Advanced Breast Carcinomas
2025-09-29 14:00 - 15:00 (Europe/London) | Online
0000Days00Hrs00Min00SecJoin this webinar to discover how digital pathology with AI evaluation is a more sensitive method for HER2-low assessment. Dr. Anikó Kovács (Department of Clinical Pathology, Sahlgrenska University Hospital, Gothenburg, Sweden) will present findings from a retrospective study on the HER2-low status of advanced breast carcinomas in core biopsies.
The aim of the study was to:

compare the outcome of HER2 scoring using conventional microscopy, digital pathology, and AI.
assess changes in HER2-low status in core biopsies, matching operation specimens, and their distant metastases.

Register for the webinar to learn more about the findings and how AI can help determine a more accurate HER2-low status, providing an exact percentage of each HER2 score within seconds with high accuracy.
Who should join?

Pathologists involved in biomarker testing
Oncologists relying on HER2-low status in treatment decisions
Anyone involved in breast cancer diagnostics or therapeutic decision-making
Anyone interested in using or developing AI models for image analysis in digital pathology

Register NowSpeakersAnikó Kovács, MD, PhD
Associate Professor, Pathologist, and Lecturer
Sahlgrenska University Hospital

Has worked in research in Sweden for the past 23 years
Breast cancer research at the Leicester University in the UK
Research background also in Japan (Kitasato University) and Hungary

Rute Pedrosa, PhD
Senior Field Application Scientist
Aiforia Technologies

Has worked at Aiforia for 2.5 years
PhD at Erasmus University Rotterdam, focusing on the pathogenesis of brain metastatic disease

Digital Diagnostic Summit 2025
2025-09-28 - 2025-09-30 | The St. Regis Deer Valley, Park City, United States
0000Days00Hrs00Min00Sec

Innovation in Action

Moving the needle from theory to actual, implemented, and viable digital pathology

Nestled at the base of the breathtaking Wasatch Mountains in the picturesque Park City, Utah, the Digital Diagnostic Summit stands as a beacon for innovation and adoption in digital pathology. Here, leading experts converge in a unique blend of professional collaboration and unconventional networking that go beyond the conference walls and into immersive experiences.

Register NowExecutive Innovation RoundtableAdam Cole, MD
Founder & CSO, TruCore Pathology Group
Giovanni Lujan, MD
Director, Digital and Computational Pathology, The Ohio State University Wexner Medical Center
Melissa Alexander, PhD, MD
Regional Medical Director, AstraZeneca
Jill Stefanelli
President and CEO, Modella AI
Jonathan Anderson
National Director of Laboratory Operations, Solaris
Matthew Leavitt, MD
Founder, DDx Foundation
Michael Martinak, MBA, SCT (ASCP)
Executive Director Anatomic Pathology, Quest Diagnostics | AmeriPath | Dermpath Diagnostics
Orly Ardon, PhD, MBA
Director of Digital Pathology Operations, Memorial Sloan Kettering Cancer Center
Wes Bernhardt
Managing Partner, OnePath Diagnostics

The ERS Congress 2025
2025-09-27 - 2025-10-01
0000Days00Hrs00Min00SecGet all the latest updates in respiratory medicine and science at the ERS Congress 2025.
This year’s theme is ‘Respiratory health around the globe’.

The ERS Congress is the world’s largest and most influential event in respiratory medicine, bringing together leading clinicians, researchers, and healthcare professionals to explore the latest advances in the field. With a rich and diverse programme covering everything from airway diseases and sleep disorders to thoracic oncology and critical care, the congress offers valuable learning opportunities for professionals at all career stages.
Attendees can benefit from expert-led symposia, workshops, and skills training. The congress also emphasizes patient involvement, with strong collaboration from the European Lung Foundation.

Register NowMeet our partner
